Fulgent Genetics, INC Form 4 insider transactions

Fulgent Genetics CFO and Treasurer Paul Kim reported an increase in his beneficial ownership of common stock following multiple restricted stock unit vestings and associated tax withholdings.

Fulgent Genetics' President and COO, Jian Xie, increased his beneficial ownership through the vesting of restricted stock units and a new grant, alongside tax-related share withholdings.

Fulgent Genetics' Chief Scientific Officer, Hanlin Gao, reported the vesting of various restricted stock units and associated tax withholdings, resulting in a net increase in beneficial ownership.

Fulgent Genetics CEO Ming Hsieh reported significant RSU vesting events and a new restricted stock unit grant, alongside shares withheld for tax obligations.

Fulgent Genetics' Chief Scientific Officer, Hanlin Gao, disposed of 1,331 shares of common stock to cover tax withholding obligations related to vested restricted stock units.

Fulgent Genetics' President and COO, Jian Xie, disposed of 4,711 shares of common stock to cover tax liabilities related to restricted stock unit vesting.

Fulgent Genetics CFO Paul Kim disposed of 3,004 shares of common stock to cover tax withholding obligations related to RSU vesting.

Fulgent Genetics' CFO and Treasurer, Paul Kim, disposed of 1,131 shares of common stock to cover tax withholding obligations related to RSU vesting.

Fulgent Genetics' President and COO, Jian Xie, sold 1,140 shares of common stock to cover tax liabilities from vested restricted stock units.

Fulgent Genetics' Chief Scientific Officer, Hanlin Gao, sold 1,075 shares of common stock to cover tax liabilities from vested restricted stock units.

Fulgent Genetics President and COO Jian Xie sold 1,198 shares of common stock to cover tax liabilities from vested restricted stock units.

Fulgent Genetics' Chief Scientific Officer, Hanlin Gao, sold 943 shares of common stock on November 28, 2025, to cover tax withholding obligations related to RSU vesting.

Fulgent Genetics' CFO and Treasurer, Paul Kim, disposed of 1,166 shares of common stock to cover tax withholding obligations related to vested restricted stock units.

Fulgent Genetics CEO Ming Hsieh disposed of 2,944 shares of common stock at $30.15 per share to cover tax liabilities from RSU vesting.

Fulgent Genetics CFO Paul Kim reported a routine disposition of 671 common shares to cover tax obligations from vested restricted stock units.

Fulgent Genetics President and COO, Jian Xie, sold 681 shares of common stock to cover tax withholding obligations related to vested restricted stock units.

Fulgent Genetics' Chief Scientific Officer, Hanlin Gao, sold 535 shares of common stock to cover tax withholding obligations related to RSU vesting.

Fulgent Genetics CEO Ming Hsieh disposed of 2,116 shares of common stock to cover tax withholding obligations related to RSU vesting.

Fulgent Genetics' President and COO, Jian Xie, reported the sale of 10,000 shares for tax planning and gifted another 10,000 shares to a family foundation.

Fulgent Genetics' Chief Scientific Officer, Hanlin Gao, disposed of 1,642 shares of common stock to cover tax obligations related to restricted stock unit vesting.

Fulgent Genetics' CFO, Paul Kim, disposed of 2,743 shares of common stock to cover tax withholding obligations related to vested restricted stock units.

Fulgent Genetics President and COO Jian Xie disposed of 4,353 shares of common stock to cover tax obligations related to RSU vesting.

Fulgent Genetics' Chief Scientific Officer, Hanlin Gao, sold 1,063 shares of common stock at a weighted-average price of $22.0267 to cover tax withholding obligations from RSU vesting.

Fulgent Genetics President and COO, Xie Jian, sold 1,128 shares of common stock to satisfy tax obligations related to vested restricted stock units.

Fulgent Genetics CFO Paul Kim disposed of 1,131 common shares at $22.17 each to satisfy tax withholding obligations related to restricted stock unit vesting.

Fulgent Genetics' President and COO, Jian Xie, reported the sale of 1,199 common shares on August 27, 2025, to cover tax withholdings from RSU vesting.

Fulgent Genetics CEO Ming Hsieh reported the withholding of 2,944 shares to cover tax obligations from restricted stock unit vesting.

Fulgent Genetics CFO Paul Kim disposed of 1,166 shares of common stock to cover tax liabilities related to restricted stock unit vesting.

Fulgent Genetics' Chief Scientific Officer, Hanlin Gao, sold 943 shares of common stock for $21.4847 per share to cover tax withholding obligations from RSU vesting.

Fulgent Genetics' President and COO, Jian Xie, sold 696 shares of common stock to cover tax withholding obligations related to vested restricted stock units.